Lilly Just Reported More Than Half of Patients on Its New Weight Loss Drug Lost 20% of Their Body Weight — and a Third Lost 25%. Here's How the News Could Shake Up the Obesity Drug Market
Key PointsTRIUMPH-2 contains retatrutide, a triple agonist weight loss drug.